LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $94,923 | +578.0% | 1,421 | +1444.6% | 0.01% | +600.0% |
Q4 2021 | $14,000 | +250.0% | 92 | +187.5% | 0.00% | – |
Q3 2021 | $4,000 | -94.6% | 32 | -95.9% | 0.00% | -100.0% |
Q3 2020 | $74,000 | +428.6% | 780 | +486.5% | 0.01% | +300.0% |
Q2 2020 | $14,000 | – | 133 | +1377.8% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 9 | -98.7% | 0.00% | -100.0% |
Q4 2019 | $73,000 | -49.3% | 705 | -51.3% | 0.01% | -50.0% |
Q3 2019 | $144,000 | +1100.0% | 1,447 | +1347.0% | 0.01% | +1300.0% |
Q1 2019 | $12,000 | -95.8% | 100 | -95.3% | 0.00% | -96.4% |
Q4 2018 | $289,000 | +556.8% | 2,137 | +410.0% | 0.03% | +460.0% |
Q1 2017 | $44,000 | -90.6% | 419 | -90.9% | 0.01% | -90.4% |
Q3 2016 | $467,000 | +2235.0% | 4,581 | +2190.5% | 0.05% | +1200.0% |
Q2 2015 | $20,000 | -60.0% | 200 | -78.9% | 0.00% | -75.0% |
Q4 2014 | $50,000 | -31.5% | 949 | -13.7% | 0.02% | -5.9% |
Q1 2014 | $73,000 | +1360.0% | 1,100 | +1000.0% | 0.02% | +750.0% |
Q4 2013 | $5,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |